Anpac Bio Medical Analysis
| ANPCDelisted Stock | USD 4.37 0.20 4.38% |
Anpac Bio Medical is overvalued with Real Value of 4.15 and Hype Value of 4.37. The main objective of Anpac Bio delisted stock analysis is to determine its intrinsic value, which is an estimate of what Anpac Bio Medical is worth, separate from its market price. There are two main types of Anpac Bio's stock analysis: fundamental analysis and technical analysis.
The Anpac Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Anpac Bio's ongoing operational relationships across important fundamental and technical indicators.
Anpac |
Anpac Stock Analysis Notes
The company recorded a loss per share of 11.45. Anpac Bio Medical had not issued any dividends in recent years. The entity had 1:20 split on the 4th of November 2022. AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the Peoples Republic of China. The company was incorporated in 2010 and is headquartered in Lishui, the Peoples Republic of China. Anpac Bio-Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people. For more info on Anpac Bio Medical please contact Haohan Xu at 86 57 8205 1666 or go to https://www.anpacbio.com.Anpac Bio Medical Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Anpac Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Anpac Bio Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Anpac Bio Medical is not yet fully synchronised with the market data | |
| Anpac Bio Medical has a very high chance of going through financial distress in the upcoming years | |
| Anpac Bio Medical currently holds 19.81 M in liabilities with Debt to Equity (D/E) ratio of 1.44, which is about average as compared to similar companies. Anpac Bio Medical has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Anpac Bio's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 12.04 M. Net Loss for the year was (103.6 M) with profit before overhead, payroll, taxes, and interest of 12.25 M. | |
| Anpac Bio Medical currently holds about 462 K in cash with (55.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02. |
Anpac Bio Medical Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Anpac Bio previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 30th of May 2023 Upcoming Quarterly Report | View | |
| 31st of March 2023 Next Fiscal Quarter End | View |
Anpac Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 27.41 M.Anpac Bio Outstanding Bonds
Anpac Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Anpac Bio Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Anpac bonds can be classified according to their maturity, which is the date when Anpac Bio Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Anpac Bio Predictive Daily Indicators
Anpac Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Anpac Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Anpac Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Anpac Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Anpac shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Anpac Bio. By using and applying Anpac Stock analysis, traders can create a robust methodology for identifying Anpac entry and exit points for their positions.
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the Peoples Republic of China. The company was incorporated in 2010 and is headquartered in Lishui, the Peoples Republic of China. Anpac Bio-Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Anpac Bio to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Anpac Stock
If you are still planning to invest in Anpac Bio Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anpac Bio's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |